CSIMarket
 

Ainos Inc   (NASDAQ: AIMD)

Ainos Inc 's

Competitiveness




 

AIMD Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Ainos Inc reported Revenue decrease in the 1 quarter 2026 year on year by -99.85 %, despite the revenue increase by the most of its competitors of 7.41 %, recorded in the same quarter.

List of AIMD Competitors





Revenue Growth Comparisons




Net Income Comparison


Ainos Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 31.02 %

<<  AIMD Stock Performance Comparisons



  

Overall company Market Share Q1 2026

Overall company, revenue fell by -99.85 % and company lost market share, to approximately 0 %.




<<  More on AIMD Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Ainos Inc




Galera Therapeutics Inc
Share Performance



+19,052.94%
30 Days



Galera Therapeutics Inc
Profile

Galera Therapeutics Inc is a pharmaceutical company that operates under an innovative business model focused on developing transformative therapies to treat cancer. They utilize a combination of in-house research, strategic partnerships, and scientific collaborations to discover, develop, and commercialize novel drug candidates. By leveraging their expertise and a patient-centric approach, Galera Therapeutics aims to revolutionize cancer treatment and improve patient outcomes.

More about Galera Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 8.018 mill. $ - mill. $ 63.518 mill.


Longeveron Inc
Share Performance



-3.62%
Over The Past 5 Days



Longeveron Inc
Profile

Longeveron Inc's business model involves the development and commercialization of regenerative medicine products using mesenchymal stem cells for various medical conditions.

More about Longeveron Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 208.661 mill. $ 1.187 mill. $ -23.474 mill.


Lunai Bioworks Inc
Share Performance



-85.36%
One Year



Lunai Bioworks Inc
Profile

Lunai Bioworks is a pre-clinical biotechnology company focused on developing cell, gene, and immunotherapy treatments for cancer.

More about Lunai Bioworks Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 8.123 mill. $ 0.021 mill. $ -128.284 mill.


Moleculin Biotech Inc
Share Performance



-70.12%
This Quarter



Moleculin Biotech Inc
Profile

Moleculin Biotech Inc is a biopharmaceutical company that develops innovative cancer therapies by targeting key enzymes and signaling pathways involved in the progression of tumors. Their business model revolves around conducting preclinical and clinical trials to advance their drug candidates, with a focus on maximizing therapeutic impact and commercial potential.

More about Moleculin Biotech Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4.261 mill. $ - mill. $ -42.162 mill.


Nuwellis Inc
Share Performance



+83.21%
This Quarter



Nuwellis Inc
Profile

Nuwellis Inc.'s business model revolves around developing and commercializing innovative therapeutic solutions, predominantly focusing on fluid management to improve outcomes for patients with critical illnesses. They aim to provide advanced medical devices and solutions to healthcare professionals, addressing the pressing need for better fluid management in critical care settings.

More about Nuwellis Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.143 mill. $ 9.013 mill. $ -11.330 mill.

16 more competitors available

Sign in to see all competitors

Sources: Ainos Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Ainos Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.